- Home
- CPS vs FDMT Comparison
CPS vs FDMT Comparison
Compare CPS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPS
- FDMT
- Stock Information
- Founded
- CPS 1960
- FDMT 2013
- Country
- CPS United States
- FDMT United States
- Employees
- CPS N/A
- FDMT N/A
- Industry
- CPS Auto Parts:O.E.M.
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- CPS Consumer Discretionary
- FDMT Health Care
- Exchange
- CPS Nasdaq
- FDMT Nasdaq
- Market Cap
- CPS 462.2M
- FDMT 391.8M
- IPO Year
- CPS N/A
- FDMT 2020
- Fundamental
- Price
- CPS $33.47
- FDMT $9.61
- Analyst Decision
- CPS Hold
- FDMT Strong Buy
- Analyst Count
- CPS 1
- FDMT 8
- Target Price
- CPS $12.00
- FDMT $30.63
- AVG Volume (30 Days)
- CPS 160.1K
- FDMT 688.5K
- Earning Date
- CPS 10-30-2025
- FDMT 11-12-2025
- Dividend Yield
- CPS N/A
- FDMT N/A
- EPS Growth
- CPS N/A
- FDMT N/A
- EPS
- CPS 1.65
- FDMT N/A
- Revenue
- CPS $2,719,148,000.00
- FDMT $33,000.00
- Revenue This Year
- CPS $2.31
- FDMT $9,656.76
- Revenue Next Year
- CPS $3.69
- FDMT N/A
- P/E Ratio
- CPS $20.17
- FDMT N/A
- Revenue Growth
- CPS N/A
- FDMT N/A
- 52 Week Low
- CPS $10.38
- FDMT $2.24
- 52 Week High
- CPS $40.67
- FDMT $9.84
- Technical
- Relative Strength Index (RSI)
- CPS 41.38
- FDMT 63.90
- Support Level
- CPS $33.14
- FDMT $8.11
- Resistance Level
- CPS $37.36
- FDMT $9.03
- Average True Range (ATR)
- CPS 1.41
- FDMT 0.52
- MACD
- CPS -0.80
- FDMT -0.01
- Stochastic Oscillator
- CPS 13.98
- FDMT 76.79
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.